Bank of New York Mellon’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.28M | Sell |
58,778
-9,447
| -14% | -$206K | ﹤0.01% | 2975 |
|
2025
Q1 | $1.26M | Buy |
68,225
+222
| +0.3% | +$4.11K | ﹤0.01% | 2909 |
|
2024
Q4 | $1.81M | Sell |
68,003
-318
| -0.5% | -$8.47K | ﹤0.01% | 2785 |
|
2024
Q3 | $1.61M | Buy |
68,321
+38,474
| +129% | +$904K | ﹤0.01% | 2853 |
|
2024
Q2 | $554K | Buy |
29,847
+7,140
| +31% | +$132K | ﹤0.01% | 3522 |
|
2024
Q1 | $406K | Buy |
+22,707
| New | +$406K | ﹤0.01% | 3643 |
|